Veracyte (VCYT) Gross Profit (2012 - 2026)

Veracyte has disclosed Gross Profit across 15 years of filings, most recently posting $101.2 million for Q1 2026.

• Gross Profit for Q1 2026 came in at $101.2 million, up 27.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $384.2 million (up 21.89% YoY), and the FY2025 annual result was $362.5 million, up 21.6% from the prior year.
• Gross Profit came in at $101.2 million for Q1 2026 at Veracyte, down from $102.0 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $102.0 million in Q4 2025 to a low of $44.0 million in Q1 2022.
• The 5-year median for Gross Profit is $64.8 million (2023), against an average of $70.3 million.
• Across the five-year window, Gross Profit soared 115.75% in 2022 and grew 10.97% in 2024, its largest moves.
• Veracyte's Gross Profit stood at $56.2 million in 2022, then climbed by 15.34% to $64.8 million in 2023, then increased by 21.56% to $78.8 million in 2024, then increased by 29.48% to $102.0 million in 2025, then fell by 0.8% to $101.2 million in 2026.
• The last three Gross Profit figures came in at $101.2 million (Q1 2026), $102.0 million (Q4 2025), and $91.3 million (Q3 2025), per Business Quant data.